1. Bobranski B., Syper L. (1961): Studies of the metabolism of 5-allyl-5-(-hydroxypropyl)-barbituric acid in the human body. Arch. Immunol. ITerapii Dosw. 9: 579–591.
2. Bobranski B., Prelicz D., Syper L., Wojtowski R. (1960): On the isomerisation of 5-allyl-5-(-hydroxypropyl)-barbituric acid. Bull. Acad. Pol. Sci. 8: 475–479.
3. Bobranski B., Syper L., Witon J. (1965): Metabolism of-allyl-allophany-valerolactone. Arch. Immunol. Ther. Exp. (Warsz) 13: 672–675.
4. Hermann T., Kulbiej J. (1979): Kinetics and mechanism of decomposition of some derivatives of 5-allylbarbituric acid IV. Dependence of kinetics of solvolysis of 5-allyl-5-(21hydroxypropyl)-barbituric acid upon pH. Acta Pol. Pharm. 36: 51–59.
5. Frochaux-Zeidler E.L., Testa B. (1980): Metabolic investigations of Proxibarbal, 5-allyl-5-(2-hydroxypropyl)-barbituric acid in vitro. Pharm. Acta Helv. 55: 79–83.